__NUXT_JSONP__("/drugs/Bapotulimab", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"2359413-58-2",chebiId:b,chemicalFormula:b,definition:"A mouse\u002Fhuman cross-reactive immunoglobulin G2 (IgG2) monoclonal antibody against the immune checkpoint immunoglobulin-like domain containing receptor 2 (ILDR2; Chromosome 1 Open Reading Frame 32; C1orf32), with potential immune checkpoint inhibitory and antineoplastic activities. Upon administration, bapotulimab targets, binds to and inhibits ILDR2, thereby blocking the immunosuppressive activity of ILDR2. This prevents ILDR2-mediated inhibition of T-cell activities and induces a cytotoxic T-lymphocyte (CTL) response against tumor cells. ILDR2, a type I transmembrane protein belonging to the B7 family of immunomodulatory receptors, negatively regulates T-cell responses.",fdaUniiCode:"I92BM16NTD",identifier:"C156490",preferredName:a,semanticType:"Immunologic Factor",subclassOf:["C129822","C20401"],synonyms:["Anti-ILDR2 Inhibitor BAY1905254","Anti-ILDR2 Monoclonal Antibody BAY 1905254","Anti-immunoglobulin-like Domain Containing Receptor 2 MoAb BAY1905254","BAPOTULIMAB","BAY 1905254","BAY-1905254","BAY1905254",a,"ILDR2 Function-blocking Antibody BAY1905254","Immune Checkpoint Inhibitor BAY1905254"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FBapotulimab",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Bapotulimab","","2021-10-30T13:34:24.003Z")));